Chronic Kidney Disease (CKD) is a long-term condition characterized by a gradual loss of kidney function over time. While there's no cure for CKD, management and treatment strategies aim to slow its progression, manage symptoms, and reduce complications. Here are some comprehensive strategies and approaches for managing CKD:

Medical Management
Blood Pressure Control:

Use of antihypertensive medications such as ACE inhibitors or ARBs, which can also protect kidney function.
Regular monitoring and maintaining blood pressure within target ranges.
Blood Sugar Control (for Diabetic Patients):

Tight control of blood glucose levels to prevent further kidney damage.
Use of medications like SGLT2 inhibitors and GLP-1 receptor agonists that have renal benefits.
Cholesterol Management:

Use of statins or other lipid-lowering agents to reduce cardiovascular risk.
Anemia Management:

Use of erythropoiesis-stimulating agents (ESAs) and iron supplements to manage anemia commonly associated with CKD.
Phosphate and Calcium Balance:

Use of phosphate binders and vitamin D supplements to maintain bone health and prevent mineral and bone disorder in CKD.
Lifestyle Modifications
Dietary Adjustments:

Low-sodium diet to help control blood pressure.
Low-protein diet to reduce the kidneys' workload.
Avoiding high-phosphorus foods to prevent mineral imbalance.
Maintaining a healthy weight through balanced nutrition.
Fluid Management:

Proper hydration while avoiding overconsumption of fluids to prevent swelling and high blood pressure.
Smoking Cessation:

Quitting smoking to improve overall cardiovascular health and reduce further kidney damage.
Regular Exercise:

Engaging in moderate physical activity to improve cardiovascular health and maintain a healthy weight.

Monitoring and Follow-Up
Regular Check-Ups:

Frequent monitoring of kidney function (e.g., serum creatinine, GFR) and other relevant parameters.
Regular visits to a nephrologist for specialized care.
Monitoring for Complications:

Keeping an eye on signs of worsening kidney function or complications such as fluid overload, electrolyte imbalances, and heart disease.
Advanced Treatments
Dialysis:

Hemodialysis or peritoneal dialysis for advanced CKD when the kidneys can no longer function adequately on their own.
Kidney Transplant:

Considering kidney transplantation as a long-term solution for end-stage renal disease (ESRD).
Education and Support
Patient Education:

Providing information on CKD and its management to empower patients to take an active role in their care.
Educating about the importance of medication adherence and lifestyle changes.
Support Groups:

Encouraging participation in support groups for emotional and psychological support.

Preventive Measures
Screening for At-Risk Populations:

Regular screening for individuals with risk factors such as diabetes, hypertension, and family history of kidney disease.
Early Detection and Intervention:

Early identification of CKD through routine health checks to initiate timely management and prevent progression.
Combining these approaches can help manage CKD effectively, improve quality of life, and delay the progression to more advanced stages of the disease. It is essential for patients to work closely with their healthcare providers to tailor a management plan specific to their individual needs and conditions.
Click Here for More Information: https://tinyurl.com/bd42n8a7

#kidneydisease #solution #kidneyfunction #CholesterolManagement #bloodsugarcontrol

The Truth About HPV Vaccination, Part 1: How Safe Is It, Really?
This first installment in a multi-part series about the human papillomavirus, or HPV, vaccine explores peer-reviewed scientific literature that reveals serious safety concerns about a vaccine widely regarded as safe.

The Epoch Times

Miss a day, miss a lot. Subscribe to The Defender's Top News of the Day. It's free.

By Yuhong Dong

The decline of public trust in COVID-19 vaccines significantly impacts vaccination rates against routine childhood diseases. This multiple-part series explores the international research done over the past two decades on the human papillomavirus (HPV) vaccine — believed to be one of the most effective vaccines developed to date.

Summary of Key Facts

This multiple-part series offers a thorough analysis of concerns raised about HPV vaccination following the global HPV campaign, which commenced in 2006.
In the U.S., the HPV vaccine was reported to have a disproportionately higher percentage of adverse events of fainting and blood clots in the veins. The U.S. Food and Drug Administration (FDA) acknowledges that fainting can happen following the HPV vaccine, and recommends sitting or lying down to get the shot, then waiting for 15 minutes afterward.
International scientists found that the Centers for Disease Control and Prevention’s (CDC) Vaccine Adverse Event Reporting System (VAERS) logged a substantial increase in reports of premature ovarian failure from 1.4 per year before 2006 to 22.2 per year after the HPV vaccine approval, yielding a Proportional Reporting Ratio of 46.1.
The HPV vaccine is widely regarded as one of the most effective vaccines developed to date. Nevertheless, safety issues have been raised following its approval, and in response, additional research has been published and litigation has been brought on behalf of those with a vaccine injury.

In this HPV vaccine series, Parts I and II explain how the vaccine works and the evidence suggesting there may be legitimate safety concerns. The remaining parts present questions about real-world vaccine effectiveness and identify specific ingredients which may pose harm.

The information presented here is drawn from peer-reviewed scientific literature from the U.S., Australia, Denmark, Sweden, France and Japan, as well as statistics published by public health agencies in each of these countries.

More than 100 hours of research and internal peer review among scientists with experience in infectious diseases, virology, clinical trials and vaccine epidemiology have been invested in presenting this summary of the evidence.

Large registry-based studies have identified plausible associations between HPV vaccination and autoimmune conditions, including premature ovarian insufficiency or premature ovarian failure, Guillain-Barré syndrome (GBS), postural orthostatic tachycardia syndrome and chronic regional pain syndrome.

While it is easy to be enthusiastic about recent advances in human vaccine technology, we should keep in mind that achieving real and lasting good health is much more than just the absence of a certain virus.

RFK Jr. and Brian Hooker Vax-Unvax
RFK Jr. and Brian Hooker’s New Book: “Vax-Unvax”

Order Now

What is HPV?

According to the CDC, HPV is the most common sexually transmitted infection in the U.S.

HPV is a small DNA virus infecting human cutaneous epithelial cells in the mucosa and skin. More than 150 strains of the HPV virus have been identified.

HPV infection is so common that the majority of sexually active people will get it at some point in their lives, even if they have only one or very few sexual partners. It can spread through sexual intercourse and oral sex. It can also pass between people through skin-to-skin contact, even by people who have no symptoms.

HPV infection causes genital warts, some of which can turn into cancer. For the most part, however, HPV infection is benign. More than 90% of HPV infections cause no clinical symptoms and are self-limited, meaning the virus is cleared by the body via natural immunological defenses.

HPV-associated cancers

High-risk HPV types (types 16, 18 and others) can cause cervical cell abnormalities that are precursors to cancers.

Type 16 is associated with approximately 50% of cervical cancers worldwide, and types 16 and 18 together are linked to 66% of cervical cancers.

An additional five high-risk types, 31, 33, 45, 52 and 58, are linked with another 15% of cervical cancers and 11% of all HPV-associated cancers.

Infection with a high-risk HPV type is associated with a higher chance of the development of cervical cancer but, by itself, HPV infection is not the sole risk factor to cause cancer. There are many other reasons, as discussed in this paper.

Given the prevalence of infection, it is unsurprising that globally, cervical cancer is the fourth most common cancer in women. In 2018, an estimated 570,000 women were diagnosed with cervical cancer worldwide and more than 300,000 died of the disease.

In the U.S., nearly 50,000 new HPV-associated cancers occur annually, with women infected at a slightly higher rate than men.

But in 9 out of 10 cases, HPV goes away within two years without causing health problems.

Only persistent HPV infections may lead to cancer. These infections evade the immune system’s innate cell-mediated defenses.

The incidence of cervical cancer can be controlled as a result of the implementation of routine testing and screening, including Pap and DNA tests.

HPV vaccines

Three HPV vaccines — bivalent HPV vaccine (Cervarix, 2vHPV), quadrivalent HPV vaccine (Gardasil, 4vHPV or HPV4) and 9-valent HPV vaccine (Gardasil 9, 9vHPV) — have been licensed by the FDA.

The HPV vaccine uses recombinant technology to assemble the shell of the virus — L1 capsid protein. These viral-like particles do not contain the virus genome and are not infectious.

Cervarix, developed by GlaxoSmithKline, is a bivalent vaccine against HPV types 16 and 18, that was pulled from the U.S. market in 2016 due to “very low market demand.”

Merck’s original Gardasil vaccine was designed to prevent infections from four strains (types 6, 11, 16 and 18).

On June 8, 2006, after the FDA’s fast-tracked review, Gardasil was approved for use in females ages 9 to 26 for the prevention of cervical, vulvar and vaginal cancers.

According to the label accompanying the vaccine, the ingredients in Merck’s first Gardasil vaccine were proteins of HPV, amorphous aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, polysorbate 80, sodium borate and water for injection.

On Oct. 16, 2009, the FDA approved Gardasil (HPV4) for use in boys ages 9 through 26 for the prevention of genital warts caused by HPV types 6 and 11, but not for cancer.

In 2010, it approved Gardasil for the prevention of anal cancer in males and females ages 9 to 26.

Four years later, the FDA approved an updated vaccine, Merck’s Gardasil 9, for use in girls ages 9 to 26 and boys ages 9 to 15 for the prevention of cervical, vaginal and anal cancers.

Gardasil 9 contains the same ingredients as Gardasil, but offers protection against nine HPV strains, adding five additional types (HPV types 31, 33, 45, 52 and 58).

The current HPV vaccination schedule recommended by the CDC is two doses for both boys and girls aged 11 or 12. However, it is approved for children as young as 9. The second dose is given 6 to 12 months after the first.

For those aged 15 and above, a three-dose schedule is implemented at one- to two-month and six-month intervals, although antibody-level studies suggest that two doses are sufficient.

The vaccine prompts the body to produce neutralizing antibodies against HPV. Antibody responses appear to peak seven months after the first dose (or one month after the third dose). The vaccine-induced antibody levels appear to be 10 to 100 times higher than those after natural infection.

The high vaccine effectiveness (90 to 98%) against the fast-growing, abnormal cells which may cause precancerous lesions in people ages 16 to 26 suggested that the best timing for vaccination was to give it to patients before they became sexually active.

HPV VAERS reports from 2 large countries

U.S. HPV vaccine adverse events

On Aug. 19, 2009, the Journal of the American Medical Association published an article authored by scientists from the FDA and CDC that reviewed the safety data for Gardasil for adverse events reported to VAERS between June 2006 through December 2008.

During that time, there were 12,424 reports of adverse events. Of these, 772 (6.2%) were serious.

VAERS is a passive surveillance system, which is subject to multiple limitations, including underreporting, unconfirmed diagnosis, lack of denominator data and no unbiased comparison groups.

Nevertheless, it is a useful and important tool for detecting postmarket safety issues with vaccines.

A disproportionately high percentage of Gardasil VAERS reports were of syncope (fainting) and venous thromboembolic events (blood clots in the veins) compared with other vaccines. There were 8.2 syncope events per 100,000 HPV doses and 0.2 venous thromboembolic events per 100,000 HPV doses reported, respectively.

The Gardasil package insert includes a warning about fainting, fever, dizziness, nausea and headaches (page 1) and notes at least the following adverse reactions reported during postmarketing surveillance (section 6.2): Guillain-Barré syndrome, transverse myelitis, motor neuron disease, venous thromboembolic events, pancreatitis and autoimmune disorders.

Australia HPV vaccines adverse events

In 2007, Australia reported an annual adverse drug reaction rate of 7.3/100,000, the highest since 2003, representing an 85% increase from 2006.

Per the analysis of the Adverse Drug Reactions System database by the Australian Department of Health and Aging, this increase was “almost entirely due to” reports following the national rollout of the three-dose HPV vaccination program for young females in April 2007; 705 of the 1,538 adverse drug reactions reported that year were from the Gardasil vaccine.

1 vaccine adverse events australia chart
In Australia, the ADR increase in 2007 was almost entirely due to the three-dose HPV vaccination program for females aged 12 to 26 years in April 2007. Credit: Australian Government Department of Health and Aged Care.
Moreover, though people may take different vaccines other than HPV, the HPV vaccine was the only suspected vaccine to cause adverse reactions in 96% of records. Twenty-nine percent had causality ratings of “certain” or “probable” and 6% were defined as “serious.”

2 vaccine types vaccine suspected chart
In these HPV-induced ADRs, 674 were suspected to be related to HPV vaccines, 203 had causality ratings of “certain” or “probable,” and 43 were defined as “serious.” Credit: Australian Government Department of Health and Aged Care.
Japan withdraws recommendation, vaccine acceptance plunged

In 2013, the Japanese raised concerns about a variety of widely reported post-vaccination serious adverse events. This led the government to suspend recommending the HPV vaccine for six years. Vaccine acceptance of HPV in Japan plunged significantly after 2013, from 42.9% to 14.3%, or from 65.4% to 3.9%.

Researchers around the world also started to investigate HPV safety. A World Health Organization (WHO) position paper released on July 14, 2017, concluded that the HPV vaccines were “extremely safe.”

The same report estimated approximately 1.7 cases of anaphylaxis per million HPV doses, that no association with GBS was found, and that syncope (fainting) was “established as a common anxiety or stress-related reaction to the injection.”

In the spring of 2022, Japan announced it was relaunching its HPV vaccination drive. Mainstream news outlets reported that for thousands of women, the cost of caution may have led to preventable HPV-induced cancers and an estimated 5,000 to 5,700 deaths.

However, a true risk-benefit analysis would also consider the number of serious adverse events prevented by putting the program on hold. The question remains: Was Japan’s caution warranted, or should their national vaccination program have continued?

Ovarian insufficiency

Concerns that the vaccine may be negatively affecting fertility have been detailed in the scientific literature.

In 2014, a peer-reviewed case series describing premature ovarian failure among Australian women following HPV vaccination was published in the Journal of Investigative Medicine.

This prompted other researchers to systematically examine the VAERS data to see if there was a connection between premature ovarian failure and Gardasil. Their study found a “potential safety signal” and concluded that “further investigations are warranted.”

VAERS analysis on ovarian failure

Two recent publications based on VAERS reports (first study, second study) found that events with a probable autoimmune background were significantly more frequent after HPV vaccination compared to other vaccinations.

The team of international scientists that did the second study evaluated reports between 1990 and 2018. They found that among the 228,341 premature ovarian failure reports, 0.1% was considered to be associated with HPV vaccination with a median age of 15 years and the time to onset was 20.5 days following vaccination.

The primary symptoms were amenorrhea (80.4%) and premature menopause (15.3%).

Most strikingly, the mean number of premature ovarian failure cases increased significantly from 1.4 per year prior to 2006 to 22.2 per year after the HPV vaccine was approved, with a proportional reporting ratio of 46.

The investigators noted that the WHO and CDC declared the HPV vaccine safe regardless of lacking adequate research into safety concerns.

For example, the authors note that in a CDC-sponsored VAERS study, 17 cases of premature ovarian failure were identified but 15 were excluded due to insufficient information to confirm the diagnosis. A separate observational study using the Vaccine Safety Datalink found no increased risk.

But this study was too underpowered to detect a signal. In addition, a cross-sectional survey study using National Health and Nutrition Examination Survey data relied on an inaccurate measurement of premature ovarian failure and self-reported HPV vaccination.

In summary, the researchers detected a strong safety signal even after accounting for a potential upswing in reports due to media coverage after the product launch (they refer to this as “notoriety bias”).

Because VAERS is a passive reporting system, the data may be incomplete and are often unconfirmed by physicians. Therefore, this study cannot provide a definitive link between HPV vaccination and premature ovarian insufficiency or premature ovarian failure but does generate a hypothetical link.

The authors of the second study conclude by insisting that “this signal warrants well-designed and appropriate epidemiological research.” They note that “if the signal is confirmed, the risk is small compared to the lifetime risk of cervical cancer.”

However, the benefit-risk profile on an individual level is not uniform.

Given the health impacts of premature ovarian insufficiency and premature ovarian failure — some of which may be irreversible — and the declining mortality rate for cervical cancer even in the prevaccine era, the risk-benefit profile for HPV vaccination remains unclear.

3 case reports on ovarian insufficiency

In the 2014 investigation mentioned above, a general practitioner in Australia noticed that three girls developed premature ovarian insufficiency following HPV4 vaccination.

As a result of vaccination, each of the girls (ages 16, 16 and 18) had been prescribed oral contraception to treat menstrual cycle irregularities. Typically, women present with amenorrhea (no periods) or oligomenorrhea (infrequent periods) as the initial symptom of premature ovarian insufficiency.

One girl had irregular periods following three doses of HPV vaccination. She then became amenorrheic and was diagnosed with premature ovarian insufficiency.

Another girl’s periods were “like clockwork” until after the third HPV dose, which she received at age 15. Her first cycle after being vaccinated for the third time started two weeks late, and her next cycle was two months late. The final cycle began nine months later. The patient had no family history of early menopause.

She was diagnosed with premature ovarian failure at 16. Lab work found hormone levels consistent with those of postmenopausal women, but her bone mineral density was normal.

The authors of this case series noted that in preclinical studies of HPV4, the five-week-old rats only conceived one litter and the only available toxicology studies appear to be on the male rodent reproductive system.

However, only two of three doses were administered prior to mating, and the overall fecundity was 95%, slightly lower than the control rats (98%) that received no vaccination prior to mating.

The dose tolerance recommendations were based on an average weight of 50 kilograms for an adolescent girl but failed to take into account that HPV4 is administered to girls ages 9 to 13 years, who range in weight from 28 to 46 kilograms.

Danish retrospective cohort study finds no link

A 2021 study also evaluated premature ovarian insufficiency in a nationwide cohort of nearly 1 million Danish females ages 11 to 34 years.

The researchers used Cox proportional hazard regression to detect an increased risk of premature ovarian insufficiency diagnosis by HPV4 vaccination status during the years 2007-2016. The hazard ratio for premature ovarian insufficiency (vaccinated versus unvaccinated) was 0.96.

One limitation was that data on age at menarche (first menstruation) and oral contraceptive use were not available. Girls who had not yet reached menarche would not be at risk for premature ovarian insufficiency, of course.

The authors excluded girls under age 15 in a sensitivity analysis and still found no signal, concluding that no association was found between HPV4 vaccination and premature ovarian insufficiency.

Reprinted with permission from The Epoch Times. Dr. Yuhong Dong, a medical doctor who also holds a doctorate in infectious diseases from China, is the chief scientific officer and co-founder of a Swiss biotech company and a former senior medical scientific expert for antiviral drug development at Novartis Pharma in Switzerland.

If you or your child suffered harm after receiving the Gardasil HPV vaccine, you may have a legal claim. Please visit Wisner Baum for a free case evaluation. Click here to watch a Gardasil litigation update interview with Wisner Baum Senior Partner Bijan Esfandiari.

The views and opinions expressed in this article are those of the authors and do not necessarily reflect the views of Children's Health Defense.

https://childrenshealthdefense.org/defender/hpv-vaccine-safety-concerns-part-1-et/


https://donshafi911.blogspot.com/2024/01/the-truth-about-hpv-vaccination-part-1.html

MMR vaxxine contains: Amino Acid, Bovine Albumin or Serum, Chick Embryo Fibroblasts, Human Serum
Albumin, Gelatin, Glutamate, Neomycin, Phosphate Buffers, Sorbitol, Sucrose, Vitamins

The MMRV (ProQuad) contains:
Bovine Albumin or Serum, Gelatin, Human Serum Albumin, Monosodium L-glutamate,
MRC-5 Cellular Protein, Neomycin, Sodium Phosphate Dibasic, Sodium Bicarbonate,
Sorbitol, Sucrose, Potassium Phosphate Monobasic, Potassium Chloride, Potassium

https://www.cga.ct.gov/2020/phdata/tmy/2020HB-05044-R000219-Wrinn,%20Chris-TMY.PDF

Do You Know What’s in a Vaccine? Chemical Ingredients
Addendum to the Childhood Vaccination Series


All Global Research articles can be read in 51 languages by activating the Translate Website button below the author’s name.

To receive Global Research’s Daily Newsletter (selected articles), click here.

Click the share button above to email/forward this article to your friends and colleagues. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

***

Over the last few decades, the number of chemicals added to foods and other products has skyrocketed. Chemicals are added to “enhance flavor”, make fruits and vegetables look fresh, extend the shelf life of packaged foods and for other invented reasons. A cornucopia of chemicals are also found in lotions and beauty products with the ostensible reason that these chemicals make beauty products feel, look, and smell nice.

Along with this increase in heavily processed foods has come increased skepticism about the necessity of inserting chemical additives into everything we touch and taste. A significant and growing segment of the US population are beginning to examine the health consequences of ingesting and absorbing these chemical-laden products.

This growing awareness about the adverse effects of ingesting and absorbing synthetic ingredients and the public’s understanding of the attendant health benefits of consuming products free from synthetic chemicals has prompted consumers to seek out organic ingredient-based items in their foods and skin lotions.

More people are showing interest in knowing about the ingredients in their food and striving to ‘eat clean.’ This increased awareness is evidenced in the steady growth of the organic food industry and trends in the natural and organic cosmetic industry where demand is higher than ever.

This same level of concern has begun to seep into the public conscience regarding a certain medical product that has mostly avoided scrutiny – the vaccine.

Having been trained to accept that this product is a customary aspect of everyday life, most people haven’t given much thought to what’s inside the vaccine vials. Rarely will the vaccine ritual in the doctor’s office include a discussion about the ingredients which are about to be injected into the patient’s body. It’s highly likely the physicians and nurses themselves don’t know the ingredients of each vaccine.

So what’s in that vial? What’s coming through that needle?

A Partial List of Ingredients

Aluminum: Aluminum salts are used in some vaccine formulations as an adjuvant. An adjuvant is a substance added to vaccines to ostensibly enhance the immune response. Examples of aluminum salts in some vaccines are aluminum hydroxide, aluminum phosphate, alum (potassium aluminum sulfate) or mixed aluminum salts.

In a 2011 study Canadian scientists Professor Christopher Shaw and Dr. Lucija Tomljenovic stated the following:

“Aluminum is an experimentally demonstrated neurotoxin and the most commonly used vaccine adjuvant. In particular, aluminum in adjuvant form carries a risk for autoimmunity, long-term brain inflammation and associated neurological complications and may thus have profound and widespread adverse health consequences.”

Multiple studies have shown that the intramuscularly injected aluminum vaccine adjuvant is absorbed into the systemic circulation and travels to different sites in the body, such as the brain, joints, and the spleen, where it accumulates and is retained for years post-vaccination.

Mercury (thimerosal): Thimerosal is an ethyl mercury-based preservative used in vials that contain more than one dose of a vaccine (multi-dose vials) to prevent germs, bacteria and/or fungi from contaminating the vaccine. While in decline some flu vaccines and childhood vaccines in multi-dose vials still utilize thimerosal.

Mercury is known to be a genotoxic agent, even in minute concentrations, which can damage the genetic information within a cell causing mutations, which may lead to cancer.

A meta-analysis epidemiological study suggested thimerosal containing vaccines significantly increased the risk of neurodevelopmental disorders.

A 2011 study suggested there may be higher rates of blood and brain mercury levels in monkeys exposed to vaccines containing thimerosal.

The American Academy of Pediatrics and the U.S. Public Health Service (1999) published a joint statement that urged “all government agencies to work rapidly toward reducing children’s exposure to mercury from all sources.”

Gelatin: Gelatin is used as a stabilizer in some vaccines licensed in the U.S. Stabilizers are added to vaccines to protect the active ingredients from degrading during manufacture, transport and storage.

Gelatin is a protein obtained from cows or pigs and produced by the partial hydrolysis of collagen extracted by boiling animal parts such as cartilage, tendons, skin, bones and ligaments in water. Some people might have a severe allergic reaction to it.

Certain vaccine viruses are grown on gelatin derived from the ligaments of pigs fed heavy doses of glyphosate in their feed. Gelatin comes from collagen which has lots of glycine.

Gelatin is one of the most commonly identified causes of allergic reactions to vaccines.

A 1999 Japanese study showed most anaphylactic reactions and some urticarial reactions to gelatin-containing measles, mumps, and rubella monovalent vaccines were associated with gelatin allergy. Based on these findings Japan removed gelatin from vaccines in 2000.

Formaldehyde: Formaldehyde is used during the manufacture of some vaccines to inactivate viruses (like polio and hepatitis A viruses) or bacterial toxins (like diphtheria and tetanus toxins).

Formaldehyde is a human carcinogen based on evidence from cancer studies in humans and is listed as aknown to be human carcinogen in the National Toxicology Program’s (NTP) Twelfth Report on Carcinogens(2011).

Phenol/Phenoxyethanol: Phenoxyethanol is used in vaccines and biologics as a preservative to prevent microbial growth.

A 2010 study, The relative toxicity of compounds used as preservatives in vaccines and biologics, assessed the relative cytotoxicity of the levels of the compounds commonly used as preservative in US licensed vaccines and found that for phenoxyethanol it was 4.6-fold, for phenol 12.2-fold and for Thimerosal >330-fold.

They concluded, “None of the compounds commonly used as preservatives in US licensed vaccine/biological preparations can be considered an ideal preservative, and their ability to fully comply with the requirements of the US Code of Federal Regulations (CFR) for preservatives is in doubt.”

Case reports (here, here and here) have suggested a link between phenoxyethanol and urticaria (hives), eczema and anaphylaxis.

Triton X-100: Triton X –100 or octylphenol ethoxylate (OPE) is a surfactant (reducing the surface tension of liquids) and stabilizer present in some influenza vaccines.

OPEs are endocrine disruptors and break down relatively easily into Octylphenols (OPs), which are more harmful. Endocrine disruptors can alter reproductive function, increase incidences of breast cancer, affect growth patterns and neurodevelopment in children and change immune function.

Squalene: Squalene is a naturally-occurring substance derived primarily from shark liver oil. When combined with other ingredients it becomes an adjuvant, which, like aluminum, is added to vaccines to elicit a stronger immune response from the body.

A 2000 study demonstrated that one intradermal injection of squalene adjuvant produced arthritis in rats.

Some believe that Gulf War Syndrome was linked to the presence of squalene in certain lots of the anthrax vaccine.

Beta-propiolactone: Beta-propiolactone (BPL) is a commonly used reagent for the inactivation of viruses for use in vaccine preparations. It has recently been used in the development of an inactivated SARS-CoV-2 vaccine preparation.

Beta-propiolactone is a known carcinogen. Local sarcomas have been produced by subcutaneous injection of beta-propiolactone in rats. In the laboratory sarcomas and squamous papillomas in mice were produced by a single subcutaneous injection of a minute amount of beta-propiolactone.

Polysorbate 80: Polysorbate 80 is present in some vaccines to stop the vaccine from separating into its component parts. In a PubMed study Polysorbate 80 was described as, “a ubiquitously used solubilizing agent that can cause severe nonimmunologic anaphylactoid reactions.”

In a pharmacological study on mice and rats Polysorbate 80 produced, “mild to moderate depression of the central nervous system with a marked reduction in locomotor activity and rectal temperature, exhibited ataxia and paralytic activity and potentiated the pentobarbital sleeping time.”

The results of that study concluded, “The results of the present study indicate that polysorbate 80 can neither be used as a solvent for isolated tissue experiments nor when considered for intravenous administration.”

Another study from the American Association for Cancer Research (AACR) suggested the dietary emulsifier polysorbate 80 may induce low-grade inflammation which may contribute to metabolic diseases and increase the potential for development in colon cancer.

Genetically modified yeast: S. cerevisiae, a species of yeast, is used in vaccines in a variety of ways. It is used as an adjuvant and now through genetic manipulation it is being used to create artificial antibodies

Studies have suggested that genetically engineered yeast used in vaccines may be a contributing factor to autoimmune disorders.

Monosodium Glutamate (MSG): Monosodium Glutamate is used in small amounts in some vaccines to keep them stable and protect them from losing potency even when exposed to heat and light.

In a study that looked at rat fertility and MSG consumption the authors found there was a negative impact on the rats’ fertility.

In another study it was noted that chronic MSG intake caused kidney dysfunction and renal oxidative stress in the animal model.

Cells From Aborted Fetus: Fetal cell lines are used to grow viruses which are then collected from the cell cultures and processed further to produce the vaccine itself.

The cell lines are propagated from lung tissue of mature aborted and used in the current manufacture of a number of routine vaccines, including measles, mumps and rubella (MMRV), diphtheria, tetanus, pertussis and polio, (DTaP-IPV), Hepatitis A and chickenpox.

Aborted fetal cells are listed on vaccine package inserts as “Human Fetal Diploid Cells.” Two aborted fetal cell lines, WI-38 and MRC-5, have been grown under laboratory conditions since the 1960s. Diploid cells (WI-38, MRC-5) vaccines have their origin in induced abortions.

The use of such cell lines can be profoundly objectionable to segments of the population who hold certain religious and/or philosophical beliefs.

The Italian vaccine research and advocacy organization Corvelva released a study in 2019 regarding the use of aborted fetal cell lines in vaccines.

In their summary they highlighted the following:

The human genomic DNA contained in this vaccine is clearly, undoubtedly abnormal, presenting important inconsistencies with a typical human genome, that is, with that of a healthy individual.
560 genes known to be associated with forms of cancer were tested and all underwent major modifications.
There are variations whose consequences are not even known, not yet appearing in the literature, but which still affect genes involved in the induction of human cancer.
What is also clearly abnormal is the genome excess showing changes in the number of copies and structural variants.
Serum From Aborted Calf Fetus Blood: The purpose for the fetal bovine serum is to provide a nutrient broth for viruses to grow in cells.

Humane Research Australia describes the process of how the blood is collected, “The blood is collected after the slaughter of a mature female cow, the mother’s uterus containing the calf fetus is removed during the evisceration process and transferred to the blood collection room. A needle is then inserted between the fetus’s ribs directly into its heart and the blood is vacuumed into a sterile collection bag.

Only fetuses over the age of three months are used otherwise the heart is considered too small to puncture. Once collected, the blood is allowed to clot at room temperature and the serum separated through a process known as refrigerated centrifugation.”

Beyond certain ethical considerations scientists have found that different bovine tissues contain different amounts of the BSE agent.

Antibiotics: Antibiotics are used during the manufacturing process of some vaccines to stop bacteria growing and contaminating the vaccine.

Antibiotics found in some vaccines include neomycin, streptomycin, polymyxin b, gentamicin and kanamycin.

Polymyxin B comes with a warning that, “This medicine has not been fully studied in pregnant women. This medicine may cause kidney problems. This medicine may cause nerve problems”, as well as a laundry list of side effects.

Similar warnings are found with streptomycin, neomycin, gentamicin, and kanamycin.

A study out of Finland raised concerns about excessive antibiotic use in early childhood which may lead to weight gain and altered gut bacteria.

What Else Could be in That Needle?

The list above is not a complete account of all the ingredients found in various vaccine cocktails. A comprehensive manufacturers’ catalog of ingredients can be found here, here and here.

The reality is that even a complete list issued by the producer doesn’t tell the entire story of what is found in vaccines.

Using an Environmental Scanning Electron Microscope equipped with an X-ray microprobe a group of Italian scientists examined 44 samples of 30 different vaccines and found dangerous contaminants, including metal toxicants in 43 of the 44 samples tested.

In the study, published in the International Journal of Vaccines and Vaccination, the researchers detected lead, chromium, nickel and other metals in every adjuvant sample tested.

Additional metal contaminants identified in 25 of the human vaccines included platinum, silver, bismuth, iron, and chromium. Foreign impurities such as zirconium, hafnium, strontium, tungsten, antimony, bismuth, cerium and were also detected in many of the vaccines tested.

The researchers commenting on their unexpected findings reported:

The quantity of foreign bodies detected and, in some cases, their unusual chemical compositions baffled us. In most circumstances, the combinations detected are very odd as they have no technical use, cannot be found in any material handbook and look like the result of the random formation occurring….In any case, whatever their origin, they should not be present in any injectable medicament, let alone in vaccines, more in particular those meant for infants. [Emphasis added]

When interviewed lead scientist Dr. Antonietta Gatti, of the National Council of Research of Italy and Scientific Director of Nanodiagnostics, explained that the discovery of vaccine impurities shocked the researchers:

Those particles should not have been there. We had never questioned the purity of vaccines before. In fact, for us the problem did not even exist. All injectable solutions had to be perfectly pure and that was an act of faith on which it seemed impossible to have doubts. For that reason, we repeated our analyses several times to be certain. In the end, we accepted the evidence.

Speculating on the potential consequences of these foreign impurities Dr. Gatti stated:

The particles, be they isolated, aggregated or clustered, are not supposed to be there… Our tissues perceive these foreign bodies as potential enemies…Unfortunately, though, the particles we found in vaccines, are not biodegradable. So, all the macrophages’ efforts will be useless, and depending on the exact chemicals involved, the particles may be especially toxic. Cytokines and pro-inflammatory substances in general are released and granulated tissue forms, enveloping the particles. This provokes inflammation which, in the long run, if locally persistent, is known to be a precursor to cancer.

Along with unlisted metal contaminants another unlisted contaminant was noted in some vaccines when a preliminary screening result from Microbe Inotech Laboratories Inc. detected glyphosate in the childhood vaccines they tested.

Merck’s MMR II vaccine had 2.671 parts per billion (ppb) of glyphosate, Sanofi Pasteur’s DTap Adacel vaccine had 0.123 ppb, Novartis’ Influenza Fluvirin had 0.331 ppb, Glaxo Smith Kline’s HepB Energix-B vaccine had 0.325 ppb, Merck’s Pneumococcal Vax Polyvalent Pneumovax 23 had 0.107 ppb of glyphosate.

These findings prompted Moms Across America to send a letter to the FDA, CDC, EPA,NIH and California Department of Health requesting that they test vaccines for glyphosate and recall contaminated vaccines.

MIT scientist Dr. Stephanie Seneff remarked on the route by which glyphosate could get into vaccines:

Collagen is a protein found in large amounts in the ligaments of cows, and these ligaments are often used in the production of gelatin. The MMR vaccine and flu vaccine viruses are grown as live cultures on gelatin sourced from cows fed high concentrations of glyphosate in their GMO Roundup­Ready feed.

What to Do?

Given the complex nature of the composition of vaccines and the paucity of information volunteered to the public on the manufacturing processes and ingredients that go into these products, how does one go about navigating this subject?

Conventional wisdom might suggest, “Ask your doctor.” But how independent are these doctors?

Where do you turn when you discover physicians and pediatricians, who have a legal duty to fully inform patients about vaccine risks and side effects, have ideological and material incentives to avoid presenting specific information that might cause a parent to question a vaccine?

What about educational materials and advice from the agencies tasked with protecting public health? Can we trust the FDA and the CDC to provide detailed and unbiased information when it is known that they get substantial amounts of money from vaccine manufacturers?

Informed consent is a principle in medical ethics and medical law that a patient must have sufficient information and understanding before making decisions about their medical care.This includes being given a thorough account of the risks and benefits of treatments, alternative treatments, the patient’s role in treatment, and their right to refuse treatment.

Informed and individualized health care decisions about any product one puts into their or their children’s body starts with being fully informed with what is in that product.

*

Note to readers: Please click the share button above. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

This article was originally published on Health Freedom Defense Fund.

Featured image is from HFDF



https://www.globalresearch.ca/do-you-know-what-vaccine/5839377

In the pursuit of optimal oral health, individuals often seek products that not only promise but also deliver tangible results. Enter ProDentim, a revolutionary oral care solution that claims to go beyond conventional dental care. Boasting a unique blend of probiotics and clinically proven ingredients, ProDentim aims to support the health of teeth and gums in a natural and effective way.

The Power of Probiotics
At the core of ProDentim's formula lies a staggering 3.5 billion probiotics. Probiotics, known for their positive impact on gut health, are increasingly recognized for their potential in supporting oral health as well. Let's delve into the key probiotic strains present in ProDentim:

Lactobacillus Paracasei:

Gum Health: Clinically proven to support gum health, Lactobacillus Paracasei may be the missing link for those seeking robust gum care.
Sinus Support: An unexpected but welcome benefit, this strain aids in maintaining open and free sinuses.
B.lactis BL-04®:

Balance of Mouth Bacteria: Supporting a healthy balance of oral bacteria is essential, and B.lactis BL-04® is designed to do just that.
Respiratory Tract Support: Beyond the mouth, this strain contributes to respiratory tract health, providing a holistic approach to well-being.
Immune System Maintenance: The strain is also claimed to play a role in maintaining a healthy immune system.
Lactobacillus Reuteri:

Anti-Inflammatory: With a focus on inflammation, this strain adds another layer of support to create a healthy oral environment.
The Proprietary Blend
ProDentim doesn't stop at probiotics. The inclusion of a proprietary blend of four plants and minerals further enhances its effectiveness:

Inulin: Fosters the growth of good bacteria, contributing to a balanced oral microbiome.
Malic Acid in Strawberries: A surprising addition known for its tooth-whitening properties.
Tricalcium Phosphate: Supports overall tooth health.
Peppermint: A natural anti-inflammatory, adding a refreshing touch.
Natural, Easy, and Safe
ProDentim prides itself on being a natural formula that is easy to use, non-GMO, without stimulants, non-habit forming, and gluten-free. This commitment to a clean and wholesome formula ensures that users can prioritize their oral health without compromising on overall well-being.

Exclusive Bonuses
Ordering ProDentim comes with more than just a promising oral health solution. Customers can enjoy two free bonuses:

Bad Breath Gone. One Day Detox:

A $109 value, this bonus provides unexpected spice and herb mixes to naturally combat bad breath.
Hollywood White Teeth at Home:

Also valued at $109, this bonus unveils a simple 10-second "Bright Teeth" method and a little-known brushing trick popular among celebrities.
Real-Life Testimonials
The efficacy of ProDentim is reinforced by the experiences of real users:

Sam Perkin (Dallas, USA): "For the first time in decades, my teeth feel amazing."
Portia Thompson (Florida, USA): "Unbelievable how much I like ProDentim. So glad my dentist recommended it."
Theo Franklin (Chicago, USA): "My gums have never looked better. It feels so good to not have to worry about my teeth."
Conclusion
ProDentim appears to be a comprehensive oral health solution, addressing various aspects from gum health and sinuses to respiratory support and immune system maintenance. Backed by positive user testimonials and an impressive blend of probiotics and natural ingredients, ProDentim stands out as a promising addition to the realm of oral care. Claim your discounted ProDentim today and embark on a journey towards better oral health while stocks last!

CLICK HERE--- https://sites.google.com/view/newprodentim2023-24/home

University of Texas at Austin - 'Golden' fossils reveal origins of exceptional preservation:

https://phys.org/news/2023-05-golden-fossils-reveal-exceptional.html

#Posidonia #Shale #Oxygenation #Jurassic #FossilPreservation #Fossils #Phosphate #Oxygen #Pyrite #Framboids #Taphonomy #Mineralogy #Paleontology